Auven Therapeutics Management LLLP-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Auven Therapeutics Management LLLP - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013106
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Auven Therapeutics Management LLLP (Auven Therapeutics Management), formerly Celtic Therapeutics Management LLLP is a private equity firm that provides life science investment strategy. The firm invests in therapeutic products or platforms. It has invested in diversified portfolio of biologic and small molecule therapeutic candidates for therapeutic indications. Auven Therapeutics Management’s investment portfolio includes ADC Therapeutics, Spirogen, Kolltan Pharmaceuticals and Sprout Pharmaceuticals. The firm also offers business development stratergy to acquire controlling ownership on therapeutic products. It operates in St. Thomas and Ft. Lauderdale, the US. Auven Therapeutics Management is headquartered in St. Thomas, Virgin islands, the US.

Auven Therapeutics Management LLLP – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Auven Therapeutics Management LLLP, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Auven Therapeutics Management LLLP, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Auven Therapeutics Management LLLP, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Auven Therapeutics Management LLLP, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Auven Therapeutics Management LLLP, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Auven Therapeutics Management LLLP, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
ADC Therapeutics To Raise US$50 Million In Venture Financing 10
Private Equity 12
ADC Therapeutics Raises USD200 Million in Private Placement of Shares 12
Licensing Agreements 13
Auven Therapeutics Enters Into Licensing Agreement With Icahn School Of Medicine At Mount Sinai For Kiacta 13
Celtic Therapeutics Enters Into Licensing Agreement With Resolvyx Pharma For RX-10045 14
Equity Offering 16
ADC Therapeutics Raises USD105 Million in Private Placement of Shares 16
ADC Therapeutics Raises USD80 Million in Private Placement of Shares 17
Acquisition 18
Sun Pharma Acquires Ocular Technologies from Auven Therapeutics 18
MedImmune Acquires Spirogen From Auven Therapeutics For US$440 Million 19
Auven Therapeutics Management LLLP – Key Competitors 21
Auven Therapeutics Management LLLP – Key Employees 22
Auven Therapeutics Management LLLP – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Auven Therapeutics Management LLLP, Pharmaceuticals & Healthcare, Key Facts 2
Auven Therapeutics Management LLLP, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Auven Therapeutics Management LLLP, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Auven Therapeutics Management LLLP, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Auven Therapeutics Management LLLP, Deals By Therapy Area, 2011 to YTD 2017 8
Auven Therapeutics Management LLLP, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
ADC Therapeutics To Raise US$50 Million In Venture Financing 10
ADC Therapeutics Raises USD200 Million in Private Placement of Shares 12
Auven Therapeutics Enters Into Licensing Agreement With Icahn School Of Medicine At Mount Sinai For Kiacta 13
Celtic Therapeutics Enters Into Licensing Agreement With Resolvyx Pharma For RX-10045 14
ADC Therapeutics Raises USD105 Million in Private Placement of Shares 16
ADC Therapeutics Raises USD80 Million in Private Placement of Shares 17
Sun Pharma Acquires Ocular Technologies from Auven Therapeutics 18
MedImmune Acquires Spirogen From Auven Therapeutics For US$440 Million 19
Auven Therapeutics Management LLLP, Key Competitors 21
Auven Therapeutics Management LLLP, Key Employees 22
Auven Therapeutics Management LLLP, Other Locations 23
Auven Therapeutics Management LLLP, Subsidiaries 23

★海外企業調査レポート[Auven Therapeutics Management LLLP-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • LivePerson, Inc. (LPSN):企業の財務・戦略的SWOT分析
    LivePerson, Inc. (LPSN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • iiNet Limited:企業の戦略・SWOT・財務情報
    iiNet Limited - Strategy, SWOT and Corporate Finance Report Summary iiNet Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Hunt’s Foodservice Ltd:企業の戦略・SWOT・財務情報
    Hunt's Foodservice Ltd - Strategy, SWOT and Corporate Finance Report Summary Hunt's Foodservice Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Showa Aircraft Industry Co., Ltd.
    Showa Aircraft Industry Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Showa Aircraft Industry Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Anaconda Mining Inc:企業の戦略・SWOT・財務分析
    Anaconda Mining Inc - Strategy, SWOT and Corporate Finance Report Summary Anaconda Mining Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Chicago Bridge & Iron Company NV (CBI)-エネルギー分野:企業M&A・提携分析
    Summary Chicago Bridge & Iron Company N.V. (CB&I) is a provider of technology and infrastructure solutions. Its services include conceptual design, technology, engineering, procurement, modularization, construction, fabrication, commissioning, maintenance, program management and environmental servic …
  • Pentair Plc (PNR):石油・ガス:M&Aディール及び事業提携情報
    Summary Pentair Plc (Pentair) is an industrial manufacturing company. It designs, manufactures and markets water treatment systems and high-performance products and solutions for filtration, separation and fluid process management. Its product portfolio includes point-of-entry and point-of-use filtr …
  • Actelion Ltd:戦略・SWOT・企業財務分析
    Actelion Ltd - Strategy, SWOT and Corporate Finance Report Summary Actelion Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • ASML Holding N.V.:企業の戦略・SWOT・財務情報
    ASML Holding N.V. - Strategy, SWOT and Corporate Finance Report Summary ASML Holding N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Nanosonics Ltd (NAN):医療機器:M&Aディール及び事業提携情報
    Summary Nanosonics Ltd (Nanosonics) is a medical technology company, which focuses on the development of technologies for infection control. Its product portfolio includes decontamination products and accessories for the prevention of hospital acquired infections (HAI). The company’s trophon EPR is …
  • Jindal Power Ltd:電力:M&Aディール及び事業提携情報
    Summary Jindal Power Ltd (JPL) a subsidiary of Jindal Steel & Power Ltd, is a power generation company that builds and operates power plants. The company offers implementation, operation and planning of thermal power, hydroelectric and renewable energy power plants. Its hydroelectric projects includ …
  • Neurocrine Biosciences Inc (NBIX):製薬・医療:M&Aディール及び事業提携情報
    Summary Neurocrine Biosciences Inc (Neurocrine) discovers, develops and commercializes pharmaceutical products for the treatment of neurologic, psychiatric and endocrine related diseases and disorders. Its lead product, Ingrezza (valbenazine) capsule is a US FDA approved selective vesicular monoamin …
  • Guyana Goldfields Inc:企業の戦略・SWOT・財務情報
    Guyana Goldfields Inc - Strategy, SWOT and Corporate Finance Report Summary Guyana Goldfields Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Al Arrab Contracting Company:企業の戦略的SWOT分析
    Al Arrab Contracting Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Aston Martin Lagonda Global Holdings Plc (AML):企業の財務・戦略的SWOT分析
    Aston Martin Lagonda Global Holdings Plc (AML) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • Uranium One Inc:企業の戦略的SWOT分析
    Uranium One Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Novant Health Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Novant Health Inc (Novant Health) is a not-for-profit, integrated healthcare service provider. The organization provides services related to assisted living, blood services, breast health, children’s services, laboratory services, emergency, laboratory services, cancer, urgent care, hospice …
  • SPI Pharma Inc:企業の戦略的SWOT分析
    SPI Pharma Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Coca-Cola HBC-Srbija d.o.o.:企業の戦略・SWOT・財務分析
    Coca-Cola HBC-Srbija d.o.o. - Strategy, SWOT and Corporate Finance Report Summary Coca-Cola HBC-Srbija d.o.o. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Whiting Petroleum Corporation:企業の戦略・SWOT・財務情報
    Whiting Petroleum Corporation - Strategy, SWOT and Corporate Finance Report Summary Whiting Petroleum Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆